Article
LPA3 Is a Precise Therapeutic Target And Potential Biomarker For Ovarian Cancer
2021-09-20
Abstract excerpt
<title>Abstract</title> <p>Current studies have demonstrated that significant increased LPA levels to be observed in ascites in patients with ovarian cancer. Although several studies have shown that Lysophosphatidic acid (LPA) related to the progression of ovarian cancer, which LPA receptors (LPARs) and G coupled protein subtypes mediated in LPA actions have not been clearly elucidated. This study aimed to clarif...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d0467b61-3bb5-5282-b74a-24e04d406d34
- DOI
- 10.21203/rs.3.rs-875460/v1
